Educative Intervention to Improve Type 2 Diabetes Mellitus Control in Corrientes (PRODIACOR)

This study has been completed.
Sponsor:
Collaborator:
National Council of Scientific and Technical Research, Argentina
Information provided by (Responsible Party):
Centro de Endocrinologia Experimental y Aplicada
ClinicalTrials.gov Identifier:
NCT01456806
First received: October 19, 2011
Last updated: October 20, 2011
Last verified: October 2011
  Purpose

Objective: To evaluate the effect of system interventions (data recording procedures and complete coverage of medications and supplies) with or without physician and/or patient education, upon the psychological, clinical, metabolic and therapeutic indicators and the costs of care of people with type 2 diabetes.

Design: Randomized 2x2 design; sample size was determined considering the change in haemoglobin A1c (primary outcome variable) using a two-sided test at the 5% level of significance, and 80% power using a paired t-test. Sample size was increased by 25% to account for non-independence and patient drop-out.

Setting: Primary care level in the city of Corrientes, Argentina with involvement of all three Argentinean health subsectors (public health, social security and the private, prepaid system).

Participants: 36 general practitioners and 468 adults (62-71% women, mean age 62 years) with type 2 diabetes. Patients of the participating physicians (nine in each group), were randomly selected and assigned to one of four groups (117 patients each): control, provider education, patient education, and provider/patient education.

Intervention: Structured group education programmes were delivered to provider and/or people with type 2 diabetes by trained professionals; identical system interventions were applied to all four groups.

Main outcome measures: Body mass index, blood pressure, fasting glucose, haemoglobin A1c levels, lipid profile, drug consumption, resource use, and patient well being (WHO-5 questionnaire and Lowe score), at baseline and up to 42 months at every 6 months intervals.


Condition Intervention
Type 2 Diabetes
Other: Education

Study Type: Interventional
Study Design: Allocation: Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Factorial Assignment
Masking: Open Label
Official Title: Programme of Diabetes Education in the City of Corrientes (PRODIACOR): Clinical, Metabolic and Economic Outcomes of a Prospective-randomized Trial Based on Different Patient-centered Educational Strategies for People With Type 2 Diabetes

Resource links provided by NLM:


Further study details as provided by Centro de Endocrinologia Experimental y Aplicada:

Primary Outcome Measures:
  • HbA1c [ Time Frame: 42 months ] [ Designated as safety issue: No ]

Secondary Outcome Measures:
  • Quality of Care Indicators [ Time Frame: 42 months ] [ Designated as safety issue: No ]
    Body mass index, blood pressure, fasting glucose, lipid profile, drug consumption, resource use, and patient well being (WHO-5 questionnaire and Lowe score)


Enrollment: 468
Study Start Date: December 2006
Study Completion Date: July 2010
Primary Completion Date: March 2007 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
No Intervention: Patients and provider non educated
In this arm neither the patients nor the providers have attended the groupal education courses
Other: Education
Structured group education programmes were delivered to provider and/or people with type 2 diabetes by trained professionals; identical system interventions were applied to all four groups.
Other Name: Diabetes Education
Active Comparator: Provider educated
Provider attend the interactive group education, while patients do not.
Other: Education
Structured group education programmes were delivered to provider and/or people with type 2 diabetes by trained professionals; identical system interventions were applied to all four groups.
Other Name: Diabetes Education
Active Comparator: Patients Educated
Patients attend the interactive group education, while providers do not.
Other: Education
Structured group education programmes were delivered to provider and/or people with type 2 diabetes by trained professionals; identical system interventions were applied to all four groups.
Other Name: Diabetes Education
Active Comparator: Providers/Patients Educated
Provider and Patients both attend the interactive group education.
Other: Education
Structured group education programmes were delivered to provider and/or people with type 2 diabetes by trained professionals; identical system interventions were applied to all four groups.
Other Name: Diabetes Education

  Show Detailed Description

  Eligibility

Ages Eligible for Study:   18 Years to 75 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Adults Patients with type 2 diabetes
  • Being regularly attended at the doctors office during at least one year

Exclusion Criteria:

  • Newly diagnosed type 2 diabetes
  • Advanced stage of chronics complications (End-stage-kidney disease)
  • Heart Failure.
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT01456806

Locations
Argentina
CENEXA (UNLP-CONICET La PLata)
La Plata, Buenos Aires, Argentina, 1900
Sponsors and Collaborators
Centro de Endocrinologia Experimental y Aplicada
National Council of Scientific and Technical Research, Argentina
Investigators
Study Director: Juan J Gagliardino, MD CENEXA (UNLP-CONICET La Plata)
  More Information

Publications:
Additional publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Responsible Party: Centro de Endocrinologia Experimental y Aplicada
ClinicalTrials.gov Identifier: NCT01456806     History of Changes
Other Study ID Numbers: 1374/2006 (ACC)
Study First Received: October 19, 2011
Last Updated: October 20, 2011
Health Authority: Argentina: Ministry of Health

Keywords provided by Centro de Endocrinologia Experimental y Aplicada:
T2DM
Cardiovascular risk factors
Metabolic control
Well-being
Cost
Cost-consequence

Additional relevant MeSH terms:
Diabetes Mellitus
Diabetes Mellitus, Type 2
Glucose Metabolism Disorders
Metabolic Diseases
Endocrine System Diseases

ClinicalTrials.gov processed this record on July 28, 2014